SCHEMBL19987739

SCHEMBL19987739

NC(=O)C1(C(=O)N(c2ccc(F)cc2)c2ccc(Oc3ccnc4cc(OCCN5CCOCC5)ncc34)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 13/20 0.51
KDR P35968 5/20 0.51
AXL P30530 9/20 0.43
MERTK Q12866 7/20 0.43
BTK Q06187 3/20 0.43
AURKA O14965 3/20 0.43
LCK P06239 3/20 0.43
TEK Q02763 3/20 0.43
MST1R Q04912 3/20 0.43
EGFR P00533 3/20 0.43
RET P07949 3/20 0.43
TEC P42680 2/20 0.43
TXK P42681 2/20 0.43
BLK P51451 2/20 0.43
BMX P51813 2/20 0.43
ERBB4 Q15303 2/20 0.43
RPS6KB1 P23443 2/20 0.43
MAPK9 P45984 2/20 0.43
FGFR2 P21802 2/20 0.43
RIPK2 O43353 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19987810 0.92 MET (0.49) METKDRAXLMERTKBTK
SCHEMBL19987725 0.87 MET (0.46) METKDRAXLMERTKBTK
SCHEMBL20478186 0.86 MET (0.43) METKDRAXLMERTKBTK
SCHEMBL19987707 0.84 MET (0.43) METKDRAXLMERTKBTK
SCHEMBL19987757 0.84 MET (0.49) METKDRAXLMERTKBTK
SCHEMBL372071 0.84 MET (0.73) METKDRAXLMERTKBTK
SCHEMBL18256906 0.84 MET (0.71) METKDRAXLMERTKBTK
SCHEMBL19987709 0.83 MET (0.41) METKDRAXLMERTKBTK
SCHEMBL19987754 0.81 MET (0.45) METKDRAXLMERTKBTK
SCHEMBL19987720 0.81 MET (0.45) METKDRAXLMERTKBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US claimed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US claimed
EP-3299369-B1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2020-11-11 EP disclosed
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US disclosed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US disclosed
EP-3299369-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2018-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF MET, MERTK, DMPK MET 1/4885KDR 210/4885AXL 212/4885
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof MET, MERTK, DMPK MET 1/4885KDR 210/4885AXL 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.